• Explore /
  • Poster
  • / Beyond TILs: Predictors of pathologic complete response (pCR) in triple-negative breast cancer (TNBC) patients with moderate tumor-infiltrating lymphocytes (TIL) receiving neoadjuvant therapy.

Beyond TILs: Predictors of pathologic complete response (pCR) in triple-negative breast cancer (TNBC) patients with moderate tumor-infiltrating lymphocytes (TIL) receiving neoadjuvant therapy.

Abstract Poster

Authors

Nour Abuhadra

Nour Abuhadra

MD Anderson Hematology/Oncology Fellowship, Houston, TX

Nour Abuhadra , Kenneth R. Hess , Jennifer Keating Litton , Gaiane M Rauch , Alastair Mark Thompson , Bora Lim , Beatriz E Adrada , Elizabeth A. Mittendorf , Senthil Damodaran , Rosalind P Candelaria , Banu Arun , Wei Tse Yang , Naoto T. Ueno , Lumarie Santiago , Rashmi Krishna Murthy , Nuhad K. Ibrahim , Aysegul A. Sahin , William Fraser Symmans , Stacy L. Moulder , Lei Huo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Neoadjuvant Therapy

Citation

J Clin Oncol 37, 2019 (suppl; abstr 572)

DOI

10.1200/JCO.2019.37.15_suppl.572

Abstract #

572

Poster Bd #

64

Abstract Disclosures

Similar Posters

First Author: Partha Ray

First Author: Bora Lim

First Author: Reva K Basho

First Author: Banu Arun